On April 2nd, we had the chance to meet with our new colleagues who will be participating in and contributing to the upcoming sessions of the new ETHICS INTERNATIONAL SOCIETY OF HEALTHCARE ETHICS AND COMPLIANCE PROFESSIONALS Spanish local chapter, in the Spring Summit 2025 that took place in Paris. Both Jennifer Arribas Hernández and me would like to take this opportunity to warmly welcome them! Ariadna Quesada and Bruno de Lacerda H. Louzano. Many thanks in advance

link to post

What a inspiring, motivating day we spend in the HBA Spain Launch Summit!!!
I was truly impressed by the generosity of the volunteers and HBA efforts and creativity they put into organizing such a significant event.
Society often underestimates female potential, and events like the one held yesterday serve as a powerful reminder of the incredible strength and capabilities women possess.
The atmosphere among the participants was joyful, relaxed, and enthusiastic. An excellent opportunity to network and recover old friends.
Thank you all for making it possible!
Congratulations to the organizers Nerea Blanque Catalina, Virginia Gonzalez Sola, Shaneze CHEBBAH, Jelena Stanisavljevic, Ana Uribarri Cisneros, Laura Requejo, Iciar Sanz de Madrid, Ester Guiu, Patrick Bartosch, Ph.D., M.A., Cecilia von Ahn Scheel

Proud that Alta Medical Services’s colour  logo is also purple! Leadership is ours!!

link to post

Yesterday the 15th Local chapter meeting of ETHICS INTERNATIONAL SOCIETY OF HEALTHCARE ETHICS AND COMPLIANCE PROFESSIONALS took place in Barcelona. Salvador Cassany Pou reviewed the last update of the “Requirements and conditions for advertising of health products addressed to the public”. Main highlighs:
- Application of the requirements when digital media are used in the dissemination of this advertising.
- More flexibility in the rules for the authorization of advertising materials – possibility of submitting joint requests for several advertising material
- Advertising materials cannot claim therapeutic actions for medical products that are not inherent to them, such as pharmacological, metabolic, or immunological effects.
- Information regarding the environmental sustainability of the product and its packaging must be visually separated from claims about its health benefits.'
- If easily understandable, the use of advertising expressions in another language are allowed
- Previous approval of the material (CPSP) must be placed next to the main product image.
The 2nd topic was ‘Denigrating competitors as an abuse of dominant position’, leaded by Yolanda Martínez Mata.

Main topics:
The European Commission's recent rulings improve control of tactics used by the pharmaceutical industry to distort competition, especially when it comes to defaming competitors.
This area affects competitiveness and confidence in pharmacovigilance and ealthcare, as it can be difficult to discern between abusive and lawful methods, particularly when it comes to offlabel use and views of the safety and efficacy of alternative goods.
Competition regulators appear to be re-interested in looking into abuses of power in the pharmaceutical industry.

We would like to sincerely express our gratitude to the excellent contribution of the speakers, and the debate generated has sparked interest among the attendees: Ángel Ramírez Martínez, so extremely helpful in the meeting organization, Àngels Comas, Anna Fina, Anna María Jambrina Albiach, Anna Morell Aloy, Anna Raber, Elena López Altés, David Vilardell, Guillem Doliu i Rallo, Júlia Nicolàs Via, Miriam Arnau Badia, Montserrat Llopart, Bruno de Lacerda H. Louzano, Elisabet Cots Prat, Adela Perisé, Pilar Manso Rubio, Sandra Nieto Magaldi, Agnès Colomés Barbarà

link to post